BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28665678)

  • 1. Why oncologists need technology to succeed in alternative payment models.
    Fargnoli B; Holleran R; Kolodziej M
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP196-SP198. PubMed ID: 28665678
    [No Abstract]   [Full Text] [Related]  

  • 2. Value-based payment models in oncology: will they help or hinder patient access to new treatments?
    Shah S; Reh G
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP188-SP190. PubMed ID: 28665677
    [No Abstract]   [Full Text] [Related]  

  • 3. Hope and some skepticism whether oncology payment models will work.
    Inserro A
    Am J Manag Care; 2019 Dec; 25(12 Spec No.):SP350-SP351. PubMed ID: 31860254
    [No Abstract]   [Full Text] [Related]  

  • 4. Can cancer care lead the way toward a value-based future?
    Macmillan K
    Am J Manag Care; 2019 Dec; 25(12 Spec No.):SP377-SP378. PubMed ID: 31860249
    [No Abstract]   [Full Text] [Related]  

  • 5. Squaring value-based payment with innovation in oncology.
    Caffrey M
    Am J Manag Care; 2018 Oct; 24(12 Spec No.):SP482-SP484. PubMed ID: 30550253
    [No Abstract]   [Full Text] [Related]  

  • 6. The Oncology Care Model-Why It Works and Why It Could Work Better: Accounting for Novel Therapies in Value-Based Payment.
    Lyss AJ; Supalla SN; Schleicher SM
    JAMA Oncol; 2020 Aug; 6(8):1161-1162. PubMed ID: 31670756
    [No Abstract]   [Full Text] [Related]  

  • 7. An oncologist's perspective: preparation for new payment models in cancer care.
    Apte SM
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP169-SP172. PubMed ID: 28665674
    [No Abstract]   [Full Text] [Related]  

  • 8. How to create successful alternative payment models in oncology.
    Miller HD
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP160-SP163. PubMed ID: 28665673
    [No Abstract]   [Full Text] [Related]  

  • 9. Making sense of advanced payment models.
    McAneny B; Grubbs SS; Birch W; Sayam Zuckerman D
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP199-SP200. PubMed ID: 28665679
    [No Abstract]   [Full Text] [Related]  

  • 10. The oncology care model and the future of alternative payment models: A gynecologic oncology perspective.
    Aviki EM; Schleicher SM; Boyd L; Liang M; Ko EM; Zanotti K; Moss H
    Gynecol Oncol; 2021 Sep; 162(3):529-531. PubMed ID: 34294415
    [No Abstract]   [Full Text] [Related]  

  • 11. The cost of treating cancer patients: treatments versus reimbursements.
    Goldstein MG
    Md Med; 2011; 12(4):15. PubMed ID: 22455202
    [No Abstract]   [Full Text] [Related]  

  • 12. Why bundled payments could drive innovation: an example from interventional oncology.
    Steele JR; Jones AK; Ninan EP; Clarke RK; Odisio BC; Avritscher R; Murthy R; Mahvash A
    J Oncol Pract; 2015 Mar; 11(2):e199-205. PubMed ID: 25604596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value and payment for oncology in the United States.
    Robinson JC
    Ann Pharm Fr; 2013 Sep; 71(5):285-90. PubMed ID: 24075699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Washington Brings Renewed Focus to Payment Models of the Future.
    Finerfrock B; Baugh N
    Radiol Manage; 2016; 38(3):10-1. PubMed ID: 27514104
    [No Abstract]   [Full Text] [Related]  

  • 15. Innovative oncology products: time to revisit the strategy development?
    Krendyukov A
    ESMO Open; 2019; 4(5):e000571. PubMed ID: 31749992
    [No Abstract]   [Full Text] [Related]  

  • 16. Alternative payment and care-delivery models in oncology: A systematic review.
    Aviki EM; Schleicher SM; Mullangi S; Matsoukas K; Korenstein D
    Cancer; 2018 Aug; 124(16):3293-3306. PubMed ID: 30141837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provider perspective: Stephen M. Schleicher, MD, MBA, addresses accountability versus control in Oncology Care First.
    Am J Manag Care; 2019 Dec; 25(12 Spec No.):SP379-SP380. PubMed ID: 31860253
    [No Abstract]   [Full Text] [Related]  

  • 18. Advanced APMs and the emerging role of immuno-oncology agents: balancing innovation and value.
    Seiden MV; Neubauer M; Verrilli D
    Am J Manag Care; 2017 Feb; 23(2 Spec No.):SP69-SP77. PubMed ID: 28298130
    [No Abstract]   [Full Text] [Related]  

  • 19. How to value technological innovation: a proposal for determining relative clinical value.
    Ladabaum U; Brill JV; Sonnenberg A; Shaheen NJ; Inadomi J; Wilcox CM; Park WG; Hur C; Pasricha PJ
    Gastroenterology; 2013 Jan; 144(1):5-8. PubMed ID: 23153872
    [No Abstract]   [Full Text] [Related]  

  • 20. Implementing Value-Based Payment Reform: A Conceptual Framework and Case Examples.
    Conrad DA; Vaughn M; Grembowski D; Marcus-Smith M
    Med Care Res Rev; 2016 Aug; 73(4):437-57. PubMed ID: 26545852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.